Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-23-040956
Filing Date
2023-08-23
Accepted
2023-08-23 07:00:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 ny20010067x2_424b3.htm 424B3 251567
  Complete submission text file 0001140361-23-040956.txt   252868
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-273977 | Film No.: 231195119
SIC: 2834 Pharmaceutical Preparations